Search research articles
Contact Us
Filters
Showing results (131-140 of 466) with videos related to
Page
of 47
Sort By:
Clinical Case Reports
|
October 9, 2025
Chronic Pulmonary Aspergillosis Secondary Infection: A Case Report of <i>Achromobacter</i> spp. Lung Infection
Marius Paulin Ngouanom Kuate, Felix Bongomin, David W Denning
Respiratory Medicine
|
October 29, 2015
Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA
David Lowes, Livingstone Chishimba, Melanie Greaves, et al.
Journal of Global Antimicrobial Resistance
|
October 22, 2020
Attainment of therapeutic posaconazole serum levels during co-administration with rifampicin
Nicholas Power, Fiona Lynch, David W Denning, et al.
BMC Pulmonary Medicine
|
February 22, 2005
Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions
B Ronan O'Driscoll, Linda C Hopkinson, David W Denning
Journal of Clinical Microbiology
|
June 21, 2019
Evaluation of LDBio <i>Aspergillus</i> ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis
Elizabeth Stucky Hunter, Malcolm D Richardson, David W Denning
Journal of Fungi (Basel, Switzerland)
|
April 27, 2018
Burden of Serious Fungal Infections in Argentina
Fernando O Riera, Juan P Caeiro, David W Denning
Mycoses
|
October 10, 2015
The burden of fungal disease in Denmark
Klaus L Mortensen, David W Denning, Maiken C Arendrup
Journal of Fungi (Basel, Switzerland)
|
March 2, 2018
The Burden of Fungal Diseases in Romania
Mihai Mareș, Valentina Ruxandra Moroti-Constantinescu, David W Denning
Emerging Microbes & Infections
|
August 1, 2019
Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS
Jacob Baker, Findra Setianingrum, Retno Wahyuningsih, et al.
The Journal of Antimicrobial Chemotherapy
|
August 25, 2014
Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
David W Denning, Nesrin Ghnan, Richard Kwizera, et al.
Page
of 47
Search research articles
Search
Showing results (131-140 of 466) with videos related to
Sort By:
Page
of 47
Clinical Case Reports
|
October 9, 2025
Chronic Pulmonary Aspergillosis Secondary Infection: A Case Report of <i>Achromobacter</i> spp. Lung Infection
Marius Paulin Ngouanom Kuate, Felix Bongomin, David W Denning
Respiratory Medicine
|
October 29, 2015
Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA
David Lowes, Livingstone Chishimba, Melanie Greaves, et al.
Journal of Global Antimicrobial Resistance
|
October 22, 2020
Attainment of therapeutic posaconazole serum levels during co-administration with rifampicin
Nicholas Power, Fiona Lynch, David W Denning, et al.
BMC Pulmonary Medicine
|
February 22, 2005
Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions
B Ronan O'Driscoll, Linda C Hopkinson, David W Denning
Journal of Clinical Microbiology
|
June 21, 2019
Evaluation of LDBio <i>Aspergillus</i> ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis
Elizabeth Stucky Hunter, Malcolm D Richardson, David W Denning
Journal of Fungi (Basel, Switzerland)
|
April 27, 2018
Burden of Serious Fungal Infections in Argentina
Fernando O Riera, Juan P Caeiro, David W Denning
Mycoses
|
October 10, 2015
The burden of fungal disease in Denmark
Klaus L Mortensen, David W Denning, Maiken C Arendrup
Journal of Fungi (Basel, Switzerland)
|
March 2, 2018
The Burden of Fungal Diseases in Romania
Mihai Mareș, Valentina Ruxandra Moroti-Constantinescu, David W Denning
Emerging Microbes & Infections
|
August 1, 2019
Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS
Jacob Baker, Findra Setianingrum, Retno Wahyuningsih, et al.
The Journal of Antimicrobial Chemotherapy
|
August 25, 2014
Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
David W Denning, Nesrin Ghnan, Richard Kwizera, et al.
Page
of 47